Mammalian tumor suppressor Int6 specifically targets hypoxia inducible factor 2 alpha for degradation by hypoxia- and pVHL-independent regulation
about
Mechanisms of translational regulation by a human eIF5-mimic proteinThe INT6 cancer gene and MEK signaling pathways converge during zebrafish developmentAdaptive cellular stress pathways as therapeutic targets of dietary phytochemicals: focus on the nervous systemInt6/eIF3e promotes general translation and Atf1 abundance to modulate Sty1 MAPK-dependent stress response in fission yeastIdentification of a putative protein profile associated with tamoxifen therapy resistance in breast cancer.Drosophila genome-wide RNAi screen identifies multiple regulators of HIF-dependent transcription in hypoxiaSilencing of int6 gene restores function of the ischaemic hindlimb in a rat model of peripheral arterial disease.Comparative analysis of novel and conventional Hsp90 inhibitors on HIF activity and angiogenic potential in clear cell renal cell carcinoma: implications for clinical evaluationControl of HIF-1alpha expression by eIF2 alpha phosphorylation-mediated translational repression.Autophagy creates a CTL epitope that mimics tumor-associated antigens.Development of lymphoproliferative diseases by hypoxia inducible factor-1alpha is associated with prolonged lymphocyte survival.Hypoxia increases sirtuin 1 expression in a hypoxia-inducible factor-dependent manner.Hypoxia-inducible factor as an angiogenic master switchINT6 interacts with MIF4GD/SLIP1 and is necessary for efficient histone mRNA translation.HAF : the new player in oxygen-independent HIF-1alpha degradation.Hypoxia and angiogenesis: regulation of hypoxia-inducible factors via novel binding factors.The emerging role of hypoxia, HIF-1 and HIF-2 in multiple myeloma.Role of VHL gene mutation in human renal cell carcinoma.Int6/eIF3e is essential for proliferation and survival of human glioblastoma cells.HIF-mediated innate immune responses: cell signaling and therapeutic implications.Treatment of pancreatic cancer with an oncolytic adenovirus expressing interleukin-12 in Syrian hamsters.An oncogenic role of eIF3e/INT6 in human breast cancer.pVHL-mediated degradation of HIF-2α regulates estrogen receptor α expression in normoxic breast cancer cells.Up-regulation Of EIF3e Is Associated with The Progression of Esophageal Squamous Cell Carcinoma and Poor Prognosis in Patients.Int6/eIF3e Silencing Promotes Placenta Angiogenesis in a Rat Model of Pre-eclampsia.
P2860
Q24634138-E034D24E-493A-4224-AC7D-3F7D0B1E9C47Q27302771-7B3532C2-1F70-4ED2-93FE-17C0146BB299Q28389419-D5BBA09D-1583-42E2-A9EA-380170916EF5Q30482974-01727B52-CE82-472D-81F2-3E1C7478B5B9Q33423808-08744ECC-0E9B-40BC-8608-EF2425B380DDQ33619194-4ADA22AA-95B8-4A06-B282-A4791A56872CQ33965740-525E2916-E402-4F1A-8069-125F48C5B3BCQ34102029-94212938-E8DC-47C0-A06E-0772B5844622Q34300719-E9BDF1BC-139C-4752-8E55-BB2EF8669DB5Q34447940-3756E9BF-9804-44F8-B5A5-DE8FE6FC3840Q34672190-26DB6463-5196-40C3-B202-C8D0BEBD0521Q34799862-561D5320-C56A-4948-9BD5-A33C09EE8858Q35535109-87130B3C-99E3-421C-B41E-25A67BA16E86Q35981897-54D1ACC7-4F84-4CCA-9B2D-D9408DA61A0AQ37450692-9EE49B71-060B-4212-B3A5-FB5317345DDDQ37639838-126C2454-AF0D-4BAA-9AB9-E996D31383BAQ37884379-BF34B825-E942-4317-B71A-A8BCC95150E3Q37962422-D2F23F86-7214-474F-8922-26E04C6FF733Q38344755-7469E6BD-F7FB-4D9F-AEE5-955EC0CA36FAQ38989126-ABCF82FF-E99D-410A-9173-0A58E9A35B68Q39505379-9AEE9541-FE7A-476C-9580-F7373C136BA5Q45384502-83F12644-205D-4A18-BC27-C2A1004C3D05Q51504343-7BC8A325-6685-4BDC-88D6-392FE37656E1Q52314879-CED97444-35B9-41BE-A2D7-0B4209EF6809Q55223615-F3E5A5D5-2C76-4421-B5A2-0E1207ADA07A
P2860
Mammalian tumor suppressor Int6 specifically targets hypoxia inducible factor 2 alpha for degradation by hypoxia- and pVHL-independent regulation
description
2007 nî lūn-bûn
@nan
2007 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Mammalian tumor suppressor Int ...... nd pVHL-independent regulation
@ast
Mammalian tumor suppressor Int ...... nd pVHL-independent regulation
@en
Mammalian tumor suppressor Int ...... nd pVHL-independent regulation
@en-gb
Mammalian tumor suppressor Int ...... nd pVHL-independent regulation
@nl
type
label
Mammalian tumor suppressor Int ...... nd pVHL-independent regulation
@ast
Mammalian tumor suppressor Int ...... nd pVHL-independent regulation
@en
Mammalian tumor suppressor Int ...... nd pVHL-independent regulation
@en-gb
Mammalian tumor suppressor Int ...... nd pVHL-independent regulation
@nl
prefLabel
Mammalian tumor suppressor Int ...... nd pVHL-independent regulation
@ast
Mammalian tumor suppressor Int ...... nd pVHL-independent regulation
@en
Mammalian tumor suppressor Int ...... nd pVHL-independent regulation
@en-gb
Mammalian tumor suppressor Int ...... nd pVHL-independent regulation
@nl
P2093
P2860
P356
P1476
Mammalian tumor suppressor Int ...... nd pVHL-independent regulation
@en
P2093
Alexander Endler
Futoshi Shibasaki
Kazuyo Uchida
P2860
P304
P356
10.1074/JBC.M700423200
P407
P577
2007-04-27T00:00:00Z